High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor

Journal of Molecular Biology

Volumn 302, Issue 3, 2000, Pages 671-689

  Moy, Franklin J ^a   Chanda, Pranab K ^a   Chen, James M ^a   Cosmi, Scott ^a   Edris, Wade ^a   Levin, Jeremy I ^b   Powers, Robert ^a  

^a PFIZER INC   (United States)

^b WYETH RESEARCH   (United States)

Author keywords

Human collagenase 3; Hydroxamic acid; Matrix metalloproteinase; NMR; Solution structure

Indexed keywords

CARBON 13; COLLAGENASE 3; HYDROXAMIC ACID; MATRIX METALLOPROTEINASE; NITROGEN 15; SULFONAMIDE;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; ENZYME STRUCTURE; GEOMETRY; HUMAN; ISOTOPE LABELING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; X RAY ANALYSIS;

EID: 0034703476     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4082     Document Type: Article

References (94)

1. An alternative 3D NMR technique for correlating backbone nitrogen-15 with side-chain Hβ resonances in larger proteins
2. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors
3. Optimized recording of heteronuclear multidimensional NMR spectra using pulsed field gradients
4. 13C J couplings in a 20-kDa protein-peptide complex
5. Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme
6. 1.8 Å crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile
7. Matrix metalloproteinases: A review
8. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analog reveals the essentials for catalysis and specificity
9. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor
10. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding
11. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
12. 1.8 Å structure of Hypoderma lineatum collagenase: A member of the serine proteinase family
13. Matrix metalloproteases: Structure-based drug discovery targets
14. Crystal structures of matrilysin-inhibitor complexes
15. Metalloproteinase inhibitors and the prevention of connective tissue breakdown
16. Structure-function correlations of calcium binding and calcium channel activities based on 3-dimensional models of human annexins I, II, III, V and VII
17. Determination of three-dimensional structures of proteins and nucleic acids in solution by nuclear magnetic resonance spectroscopy
18. The three-dimensional structure of α1-purothionin in solution: Combined use of nuclear magnetic resonance, distance geometry and restrained molecular dynamics
19. Three-dimensional structure of interleukin 8 in solution
20. Analysis of the backbone dynamics of interleukin-1β using two-dimensional inverse detected heteronuclear nitrogen-15-proton N-MR spectroscopy
21. Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteins
22. 15N NMR relaxation measurements
23. The next generation of MMP inhibitors: Design and synthesis
24. NMRPipe: A multidimensional spectral processing system based on UNIX pipes
25. Preclinical and clinical studies of MMP inhibitors in cancer
26. 15N NMR relaxation
27. Molecular cloning and expression of collagenase-3 , a novel human matrix metalloproteinase produced by breast carcinomas
28. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams
29. The impact of direct refinement against three-bond HN-C(α)H coupling constants on protein structure determination by NMR
30. An improved method for selectivity observing protons attached to carbon-12 in the presence of proton-carbon-13 spin pairs
31. Determination of pharmacophoric geometry for collagenase inhibitors using a novel computational method and its verification using molecular dynamics, NMR and X-ray crystallography
32. Bioactive conformation of stromelysin inhibitors determined by transferred nuclear Overhauser effects
33. Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy
34. The NMR structure of the inhibited catalytic domain of human stromelysin-1
35. Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography
36. The importance of not saturating water in protein NMR. Application to sensitivity enhancement and NOE measurements
37. Multiple-quantum line narrowing for measurement of H.alpha.-H.beta. J couplings in isotopically enriched proteins
38. Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR
39. Isotope-filtered 2D NMR of a protein-peptide complex: Study of a skeletal muscle myosin light chain kinase fragment bound to calmodulin
40. Three-dimensional NOESY-HMQC spectroscopy of a carbon-13-labeled protein
41. Characterization of thermotropic state changes in myosin subfragment-1 and heavy meromyosin by UV difference spectroscopy
42. Backbone dynamics of proteins as studied by nitrogen-15 inverse detected heteronuclear NMR spectroscopy: Application to staphylococcal nuclease
43. Pulse sequences for removal of the effects of cross correlation between dipolar and chemical-shift anisotropy relaxation mechanisms on the measurement of heteronuclear T1 and T2 values in proteins
44. Determination of the three-dimensional solution structure of the C-terminal domain of cellobiohydrolase I from Trichoderma reesei. A study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing
45. 13C(β) chemical shifts on protein structure determination by NMR
46. Improving the quality of NMR and crystallographic protein structures by means of a conformational database potential derived from structure databases
47. Improvements and extensions in the conformational database potential for the refinement of NMR and X-ray structures of proteins and nucleic acids
48. PROCHECK: A program to check the stereochemical quality of protein structures
49. 13C HMQC-NOESY experiment for extracting intermolecular NOE contacts in molecular complexes
50. Structural analysis of the catalytic domain of human fibroblast collagenase
51. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
52. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself
53. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors
54. Overcoming the overlap problem in the assignment of proton NMR spectra of larger proteins by use of three-dimensional heteronuclear proton-nitrogen-15 Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: Application to interleukin 1. beta
55. Rapid recording of 2D NMR spectra without phase cycling: Application to the study of hydrogen exchange in proteins
56. Spin-lattice relaxation measurements in slowly relaxing complex spectra
57. Modified spin-echo method for measuring nuclear relaxation times
58. Matrix metalloproteinase inhibitors: Current status
59. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy
60. Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase
61. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR
62. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound
63. 13CO assignments and secondary structure determination of collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor
64. Comparative sequence specificities of human 72-and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)
65. Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding
66. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical stimulated annealing calculations
67. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2
68. Proton NMR stereospecific assignments by conformational data-base searches
69. Stromelysin inhibitors designed from weakly bound fragments: Effects of linking and cooperativity
70. Intramolecular motions of a zinc finger DNA-binding domain from Xfin characterized by proton-detected natural abundance carbon-13 heteronuclear NMR spectroscopy
71. Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR
72. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions
73. Complex roles of matrix metalloproteinases in rumor progression
74. Three-dimensional triple-resonance NMR of carbon-13/nitrogen-15-enriched proteins using constant-time evolution
75. Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using nitrogen-15 relaxation measurements
76. The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy
77. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease
78. Complementarity of combinatorial chemistry and structure-based ligand design: Application to the discovery of novel inhibitors of matrix metalloproteinases
79. 13C nuclear magnetic resonance chemical shifts
80. 1.56 Å structure of mature truncated human fibroblast collagenase
81. Structure of human neutrophil collagenase reveals large S1' specificity pocket
82. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor
83. 15N-enriched proteins
84. 1J(CαHα) and protein backbone conformation
85. Solution conformation of proteinase inhibitor IIA from bull seminal plasma by proton nuclear magnetic resonance and distance geometry
86. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
87. Pseudo-structures for the 20 common amino acids for use in studies of protein conformation by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance
88. Inhibition of matrix metalloproteinases: Structure based design
89. Improved linear prediction of damped NMR signals using modified 'forward-backward' linear
90. Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a
91. Stereospecific assignments of proton-NMR methyl lines and conformation of valyl residues in the lac repressor headpiece
92. Three-dimensional carbon-13-resolved proton NOE spectroscopy of uniformly carbon-13-labeled proteins for the NMR assignment and structure determination of larger molecules